Galderma Group AG (GALD)
SIX
Closed
Oct 7, 2026
Day's Range
160.0052 wk Range
134.70Overview - GALD - Galderma Group AG
Key Statistics
Valuation
Enterprise Value
33.04B
P/E (Trailing)
‪53.97‬
P/E (Forward)
‪29.41‬
PEG Ratio
‪29.41‬
Price / Sales (TTM)
‪6.41‬
Price / Book
‪5.66‬
EV / EBITDA
‪28.77‬
Profitability
Profit Margin
‪14.57%‬
Operating Margin
‪20.23%‬
Return on Assets
‪5.35%‬
Return on Equity
‪10.82%‬
Ownership
Shares Outstanding
234.56M
Float
131.26M
Held by Insiders
‪21.02%‬
Held by Institutions
‪48.16%‬
Price stats
Beta
‪-0.11‬
50-Day Avg
‪168.57‬
200-Day Avg
‪161.49‬
Dividends
Payout Ratio
‪12.11%‬
Frequency
Annual
Analyst Consensus
17 analysts
Average price target
‪CHF 194.39‬Market Cap - GALD - Galderma Group AG
Peers - GALD - Galderma Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on SIX.
Profile Summary - GALD - Galderma Group AG
About
Galderma Group AG is a Swiss healthcare company specializing exclusively in dermatology, headquartered in Zug and founded in 1981. The company focuses on skin health through three integrated business segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. In injectable aesthetics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
